CD200 % expression was positive in 100% of CLL patients versus 56% of B-NHL and 100% of HCL patients, thus showing statistical significance in B-NHL patients (p<0.001) and no statistically significant difference was found in HCL (Table 2, Fig.1B). This evidence concerns the gene CD200 and B-cell chronic lymphocytic leukemia.